EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische Studie

C-Reactive Protein and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

Takehiko Kawaguchi, Lin Tong, Bruce M Robinson, Ananda Sen, Shunichi Fukuhara, Kiyoshi Kurokawa, Bernard Canaud, Norbert Lameire, Friedrich K Port, Ronald L Pisoni

Nephron Clinical Practice · 14.08.2010 · 117 (2) · c167-c178

DOI: 10.1159/000320116 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift Nephron Clinical Practice, online erschienen am 14.08.2010. Verfasst von Takehiko Kawaguchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Healthcare Research, Kyoto University, Graduate School of Medicine and Public Health, Kyoto, Japan. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We examined associations of C-reactive protein (CRP) levels with mortality in Japanese hemodialysis patients and trends in prevalence of CRP measurement at hemodialysis facilities internationally. To assess whether measurement of CRP may influence outcomes, we examined associations of facility prevalence of CRP measurement with mortality.

Methods

CRP measurements were from a cross-section of patients in the international Dialysis Outcomes and Practice Patterns Study (n = 610 facilities, 16,355 patients). Cox proportional hazards models assessed associations of mortality with CRP in Japan, and with a facility’s frequency of measuring CRP internationally, (except in the USA and Canada).

Results

From 2002–2004, CRP was measured in 0–19% of patients in each country, except Japan (55%). From 2005–2007, CRP was measured in ≧50% of country patients except in Canada (15%) and the USA (2%). After multivariable adjustment, the hazard ratio (HR) of death was 1.6- to 2.4-fold higher (p < 0.05) for various categories of CRP levels >3 mg/l (vs. 3 mg/l. Greater use of CRP may lead to improved patient care as suggested by the association of greater CRP measurement with lower cardiovascular mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersC-Reactive ProteinCardiovascular DiseasesComorbidityFemaleHumansIncidenceInternationalityKidney Failure, ChronicMaleMiddle AgedRenal DialysisReproducibility of ResultsRisk AssessmentRisk FactorsSensitivity and SpecificitySurvival AnalysisSurvival RateTreatment Outcome

Substanzen

BiomarkersC-Reactive Protein

Autor:innen und Institutionen

  • Department of Epidemiology and Healthcare Research, Kyoto University, Graduate School of Medicine and Public Health, Kyoto, Japan.

Zitieren

APA

Kawaguchi, T., Tong, L., Robinson, B. M., Sen, A., Fukuhara, S., Kurokawa, K., Canaud, B., Lameire, N., Port, F. K., & Pisoni, R. L. (2010). C-Reactive Protein and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clinical Practice, 117(2), c167-c178. https://doi.org/10.1159/000320116

Vancouver

Kawaguchi T, Tong L, Robinson BM, Sen A, Fukuhara S, Kurokawa K, et al. C-Reactive Protein and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clinical Practice. 2010;117(2):c167-c178. doi:10.1159/000320116

BibTeX
@article{Kawaguchi2010,
  author = {Kawaguchi, Takehiko and Tong, Lin and Robinson, Bruce M and Sen, Ananda and Fukuhara, Shunichi and Kurokawa, Kiyoshi and Canaud, Bernard and Lameire, Norbert and Port, Friedrich K and Pisoni, Ronald L},
  title = {C-Reactive Protein and Mortality in Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study (DOPPS)},
  journal = {Nephron Clinical Practice},
  year = {2010},
  volume = {117},
  number = {2},
  pages = {c167--c178},
  doi = {10.1159/000320116}
}
Kostenlos starten →